Tetrahydro-2-furoic acid, (+)- → HCID 86595139, compound
Reaction equation
[O:1]1[CH2:7][CH:6]([C:8]2[C:16]3[S:15][C:14]([NH2:17])=[N:13][C:12]=3[C:11]([O:18][CH3:19])=[CH:10][CH:9]=2)[CH2:5][O:4][CH2:3][CH2:2]1.[O:20]1[CH2:24][CH2:23][CH2:22][C@@H:21]1[C:25](O)=[O:26]>>[O:4]1[CH2:5][CH:6]([C:8]2[C:16]3[S:15][C:14]([NH:17][C:25]([C@H:21]4[CH2:22][CH2:23][CH2:24][O:20]4)=[O:26])=[N:13][C:12]=3[C:11]([O:18][CH3:19])=[CH:10][CH:9]=2)[CH2:7][O:1][CH2:2][CH2:3]1Participants
3
Procedure
Using 7-[1,4]dioxepan-6-yl-4-methoxy-benzothiazol-2-ylamine and (R)-tetrahydrofuran-2-carboxylic acid, the title compound was prepared as white powder. MS: m/e=379(M+H+).
Sources & evidence
- ORD record
- ord-e1cba8a0c5a2401abd0161f4ebad5812
- Source dataset
- uspto-grants-2008_05
- Patent number
- US07371748B2
Reaction notes
Loading…